Mechanism of inhibition of ribonucleoside diphosphate reductase by ga-(n)-heterocyclic aldehyde thiosemicarbazones
- 1 November 1971
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 20 (11) , 3119-3123
- https://doi.org/10.1016/0006-2952(71)90116-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Inhibition of ribonucleoside diphosphate reductase by 1-formylisoquinoline thiosemicarbazone and related compoundsBiochemistry, 1970
- Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of actionJournal of Medicinal Chemistry, 1970
- Potential antitumor agents. II. Effects of modifications in the side chain of 1-formylisoquinoline thiosemicarbazoneJournal of Medicinal Chemistry, 1969
- Potential Antitumor Agents IIIJournal of Pharmaceutical Sciences, 1968
- Potential antitumor agents. I. A series of 5-substituted 1-formylisoquinoline thiosemicarbazonesJournal of Medicinal Chemistry, 1968
- Effect of chelating agents upon the synthesis of nucleic acids and protein: Inhibition of DNA synthesis by 1-formylisoquinoline thiosemicarbazoneBiochemical and Biophysical Research Communications, 1967
- The Carcinostatic Activity of Thiosemicarbazones of Formyl Heteroaromatic Compounds.1 III. Primary CorrelationJournal of Medicinal Chemistry, 1966
- Nucleoside Triphosphate-Nucleoside Diphosphate Transphosphorylase (Nucleoside Diphosphokinase)Published by Elsevier ,1964